Molecular understanding for formulation of novel biologics
| Reference number | |
| Coordinator | Lunds universitet - Institutionen för processteknik och tillämpad biovetenskap |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | November 2025 - November 2026 |
| Status | Ongoing |
| Venture | Deepened international collaborations |
| Call | Deepened collaboration with USA, UK and Singapore within Health and Life Science |
Purpose and goal
The project aims to improve the stability of next-generation protein drugs through formulations based on molecular understanding of protein–protein and protein–excipient interactions. The goal is to establish a long-term research collaboration between Lund University and the University of Manchester to develop robust and personalized protein formulations for the future.
Expected effects and result
The project establishes a long-term research collaboration between Lund University and the University of Manchester, with potential to include additional academic and industrial partners. Using advanced methods, especially asymmetric flow field-flow fractionation (AF4), the colloidal stability of proteins is studied. The results will form the basis for major joint research proposals and international funding.
Planned approach and implementation
The project begins with strategic planning and exchanges between Lund University and the University of Manchester to identify future research opportunities. This is followed by a pilot project where new analytical methods are used to study protein–protein and protein–excipient interactions. In the later stages, a joint workshop is held with external academic and industrial partners to identify future collaborations and prepare an international research proposal.